This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a cyclopropyl ring and difluorophenyl group, makes it a valuable building block in the development of compounds targeting central nervous system disorders. It is particularly relevant in the creation of potential therapeutic agents for neurological conditions, such as anxiety, depression, and epilepsy, due to its ability to interact with specific receptors in the brain. Additionally, its unique chemical properties are explored in medicinal chemistry for designing molecules with enhanced bioavailability and metabolic stability. Researchers also investigate its role in optimizing drug candidates for improved efficacy and reduced side effects.